J1932 HCPCS code: Injection, lanreotide, (cipla), 1 mg
J1932 is the HCPCS Level II code for injection, lanreotide, (cipla), 1 mg. In 2024 Medicare paid an average of $34.40 per service for J1932 across 508,174 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 120 per day on DME suppliers. Medicare volume rose 817% from 2022 to 2024 (55,443 to 508,174 services). In 2024, about 542 clinicians billed Medicare for J1932 for 667 beneficiaries; Florida, California, Arkansas accounted for 82% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2022-10-01 |
| Last action effective | 2022-10-01 |
Who bills J1932 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 542 |
| Medicare beneficiaries | 667 |
| States with claims | 12 |
| Share of services in top 3 states (Florida, California, Arkansas) | 82% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1932, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 55,443 | 244 | $59.65 | $47.53 |
| 2023 | 444,811 | 724 | $53.59 | $42.66 |
| 2024 | 508,174 | 667 | $43.24 | $34.40 |
States with the most J1932 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 285,720 | $34.16 |
| California | 65,972 | $35.07 |
| Arkansas | 26,040 | $34.08 |
| Arizona | 21,360 | $34.71 |
| Maryland | 13,320 | $35.16 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 120 | Prescribing Information |
| outpatient hospital claims | 120 | Prescribing Information |
| practitioner claims | 120 | Prescribing Information |
What changed for J1932
- 2022-10-01: J1932 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1932?
J1932 is the HCPCS Level II code for injection, lanreotide, (cipla), 1 mg. Short descriptor: "Inj, lanreotide, (cipla) 1mg".
How much does Medicare pay for J1932?
In 2024, the average Medicare payment was $34.40 per service (average allowed $43.24).
Does Medicare cover J1932?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1932 can be billed per day?
120 on DME suppliers; 120 on outpatient hospital claims; 120 on practitioner claims (NCCI medically unlikely edits).
Related J19 codes
- J1920 — Injection, labetalol hydrochloride, 5 mg
- J1921 — Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
- J1930 — Injection, lanreotide, 1 mg
- J1931 — Injection, laronidase, 0.1 mg
- J1938 — Injection, furosemide, 1 mg
- J1939 — Injection, bumetanide, 0.5 mg
- J1940 — Injection, furosemide, up to 20 mg
- J1941 — Injection, furosemide (furoscix), 20 mg
- J1942 — Injection, aripiprazole lauroxil, 1 mg
- J1943 — Injection, aripiprazole lauroxil, (aristada initio), 1 mg
- J1944 — Injection, aripiprazole lauroxil, (aristada), 1 mg
- J1945 — Injection, lepirudin, 50 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1932
- Watch J1932 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1932
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.